NOD2 Promotes Glioblastoma Progression Through Effects on Epithelial–Mesenchymal Transition and Cancer Stemness
<b>Background</b>: Glioblastoma multiforme (GBM) represents one of the most aggressive and lethal primary brain malignancies, characterized by rapid proliferation, extensive invasiveness, and a dismal prognosis. Emerging evidence implicates nucleotide-binding oligomerization domain-containing protein 2 (<i>NOD2</i>), an intracellular pattern recognition receptor, as a potential driver of GBM progression. This study investigates NOD2's role in promoting glioblastoma through its effects on the epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) markers. <b>Methods</b>: NOD2 expression levels and survival outcomes were assessed using TCGA data from GBM tumor samples (<i>n</i> = 153) and normal brain tissues (<i>n</i> = 5). NOD2 protein expression was validated in glioma cell lines using Western blot and immunofluorescence analyses. Functional studies employed siRNA-mediated <i>NOD2</i> knockdown to evaluate effects on cellular proliferation, migration, invasion, and colony formation, while correlations between NOD2 and EMT/CSC markers were assessed. <b>Results</b>: The analysis of TCGA data revealed a significantly elevated <i>NOD2</i> expression in GBM tumors compared to normal brain tissue, with a high <i>NOD2</i> expression correlating with a reduced disease-free survival in GBM patients. All tested glioma cell lines demonstrated robust NOD2 expression. Functional analyses demonstrated that NOD2 depletion substantially impaired cellular proliferation, migration, invasion, and the colony-forming capacity. Mechanistically, siRNA-mediated <i>NOD2</i> knockdown significantly decreased the expression of EMT (Snail, SLUG, Vimentin) and CSC markers (CD44, CD133) at both protein and mRNA levels. <b>Conclusions</b>: Our results indicate that NOD2 contributes to GBM progression by influencing EMT and CSC pathways. These findings suggest NOD2's potential as a therapeutic target in glioblastoma, highlighting the need for further mechanistic studies and therapeutic exploration.
Authors
- Ji Young Lee
- Sung Sun Kim (ORCID: https://orcid.org/0000-0002-8569-2178)
- Shubhash Chandra Chaudhary
- S M Abdus Salam (ORCID: https://orcid.org/0000-0003-4347-7370)
- Nah Ihm Kim
- Eun‐Jung Ahn (ORCID: https://orcid.org/0000-0003-3718-589X)
- Kyung‐Sub Moon (ORCID: https://orcid.org/0000-0002-1129-1064)
- Eshrat Jahan
- Kyung‐Hwa Lee (ORCID: https://orcid.org/0000-0002-3935-0361)
- Jong‐Hwan Park (ORCID: https://orcid.org/0000-0003-4664-5640)
- Tae-Young Jung
Institutions
- Chonnam National University (KR)
- Chonnam National University Hwasun Hospital (KR)
Publication Details
- Journal
- Biomedicines
- Published
- 2025-08-21
- DOI
- https://doi.org/10.3390/biomedicines13082041
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00